APO-SILDENAFIL PHT sildenafil (as citrate) 20mg tablet bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-sildenafil pht sildenafil (as citrate) 20mg tablet bottle

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 28.1 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: macrogol 8000; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; hypromellose; titanium dioxide; hyprolose - sildenafil is used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of sildenafil has not been evaluated in patients currently on bosentan therapy.

SILDENAFIL tablet, film coated
SILDENAFIL powder, for suspension USA - engelsk - NLM (National Library of Medicine)

sildenafil tablet, film coated sildenafil powder, for suspension

greenstone llc - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - sildenafil is indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [see clinical studies (14)] . studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with new york heart association (nyha) functional class ii–iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). limitation of use: adding sildenafil to bosentan therapy does not result in any beneficial effect on exercise capacity [see clinical studies (14)] . sildenafil is contraindicated in patients with: risk summary limited published data from randomized controlled trials, case-controlled trials, and case series do not report a clear association with sildenafil and major birth defects, miscarriage, or adverse maternal or fetal outcomes when sildenafil is used d

SILDENAFIL SANDOZ sildenafil (as citrate) 25 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sildenafil sandoz sildenafil (as citrate) 25 mg tablet blister pack

sandoz pty ltd - sildenafil citrate, quantity: 35.1 mg (equivalent: sildenafil, qty 25 mg) - tablet, uncoated - excipient ingredients: indigo carmine aluminium lake; magnesium stearate; copovidone; microcrystalline cellulose; saccharin sodium; calcium hydrogen phosphate; croscarmellose sodium - sildenafil sandoz is indicated for the treatment of erectile dysfunction in adult males. sildenafil sandoz is not indicated for use by women.

SILDENAFIL SANDOZ sildenafil (as citrate) 100 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sildenafil sandoz sildenafil (as citrate) 100 mg tablet blister pack

sandoz pty ltd - sildenafil citrate, quantity: 140.4 mg (equivalent: sildenafil, qty 100 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; copovidone; croscarmellose sodium; saccharin sodium; indigo carmine aluminium lake; calcium hydrogen phosphate; magnesium stearate - sildenafil sandoz is indicated for the treatment of erectile dysfunction in adult males. sildenafil sandoz is not indicated for use by women.

SILDENAFIL SANDOZ sildenafil (as citrate) 50 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sildenafil sandoz sildenafil (as citrate) 50 mg tablet blister pack

sandoz pty ltd - sildenafil citrate, quantity: 70.2 mg (equivalent: sildenafil, qty 50 mg) - tablet, uncoated - excipient ingredients: indigo carmine aluminium lake; croscarmellose sodium; microcrystalline cellulose; calcium hydrogen phosphate; magnesium stearate; copovidone; saccharin sodium - sildenafil sandoz is indicated for the treatment of erectile dysfunction in adult males. sildenafil sandoz is not indicated for use by women.

APO-SILDENAFIL sildenafil (as citrate) 100mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-sildenafil sildenafil (as citrate) 100mg tablet blister pack

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 140.48 mg (equivalent: sildenafil, qty 100 mg) - tablet, film coated - excipient ingredients: macrogol 8000; titanium dioxide; hyprolose; hypromellose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium - sildenafil is indicated for the treatment of erectile dysfunction in adult males. sildenafil is not indicated for use by women.

SILDENAFIL SANDOZ PHT 20 sildenafil (as citrate) 20 mg film-coated tablets blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sildenafil sandoz pht 20 sildenafil (as citrate) 20 mg film-coated tablets blister pack

accord healthcare pty ltd - sildenafil citrate, quantity: 28.1 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; hypromellose; calcium hydrogen phosphate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; triacetin - used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of sildenafil citrate 20 mg has not been evaluated in patients currently on bosentan therapy.

SILDENAFIL VIATRIS 25 mg, comprimé pelliculé Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sildenafil viatris 25 mg, comprimé pelliculé

viatris sante - sildénafil 25 mg sous forme de : sildénafil (citrate de) - comprimé - 25 mg - pour un comprimé > sildénafil 25 mg sous forme de : sildénafil (citrate de) - urologiques, médicaments utilisés dans les troubles de l'érection - classe pharmacothérapeutique : urologiques, médicaments utilisés dans les troubles de l'érection, code atc : g04be03.sildenafil viatris appartient à un groupe de médicaments appelés inhibiteurs de la phosphodiestérase de type 5 (pde5).son action consiste à aider la relaxation des vaisseaux sanguins du pénis, favorisant l’afflux sanguin dans le pénis lors d'une excitation sexuelle. sildenafil viatris vous aidera à obtenir une érection uniquement si vous avez une stimulation sexuelle.sildenafil viatris est un traitement pour les hommes adultes souffrant de troubles de l'érection, parfois appelés impuissance ; c'est-à-dire quand un homme ne peut pas atteindre ou conserver une érection suffisante pour une activité sexuelle.

SILDENAFIL VIATRIS 50 mg, comprimé pelliculé Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sildenafil viatris 50 mg, comprimé pelliculé

viatris sante - sildénafil 50 mg sous forme de : sildénafil (citrate de) - comprimé - 50 mg - pour un comprimé > sildénafil 50 mg sous forme de : sildénafil (citrate de) - urologiques, médicaments utilisés dans les troubles de l'érection - classe pharmacothérapeutique : urologiques, médicaments utilisés dans les troubles de l'érection, code atc : g04be03.sildenafil viatris appartient à un groupe de médicaments appelés inhibiteurs de la phosphodiestérase de type 5 (pde5).son action consiste à aider la relaxation des vaisseaux sanguins du pénis, favorisant l’afflux sanguin dans le pénis lors d'une excitation sexuelle. sildenafil viatris vous aidera à obtenir une érection uniquement si vous avez une stimulation sexuelle.sildenafil viatris est un traitement pour les hommes adultes souffrant de troubles de l'érection, parfois appelés impuissance ; c'est-à-dire quand un homme ne peut pas atteindre ou conserver une érection suffisante pour une activité sexuelle.